Maxwell et al. identified that AKT, NF-κb, and MAPK pathways were involved in AG-relevant anti-cancer effects in (either ER-positive or ER-negative) breast cancer (Maxwell et al., 2017). This evidence concerns the gene AKT1 and breast carcinoma.